Vertex Pharmaceuticals Incorporated (VRTX) stock continued to rise in its latest intraday trading under the dominance of a short-term corrective bullish trend, with trading along an ascending line that supports this direction. The stock maintains positive pressure from trading above the previous 50-day SMA, while positive signals continue to appear from the relative strength indicators after the stock successfully corrected its earlier overbought levels, giving it more room to extend its gains.

Therefore, we expect the stock to rise in its upcoming trading sessions, especially as long as it remains above $414.85, targeting the resistance level of $453.50.

Today’s stock forecast: Bullish.

AT&T (T) stock declined in its latest intraday trading, ending a highly volatile session in which it managed to pare much of its early losses. The stock remains under the dominance of a steep short-term corrective bearish wave, with continued negative pressure from trading below the previous 50-day SMA. In addition, a bearish divergence has begun to form on the relative strength indicators after reaching excessively overbought levels compared to the price movement, accompanied by emerging negative signals.

Therefore, we expect the stock to decline in its upcoming trading sessions as long as the resistance level of $26.50 holds, targeting the support level of $24.00.

Today’s stock forecast: Bearish.

Tesla, Inc (TSLA) stock declined in its latest intraday trading as it attempts to gain positive momentum that could help it recover and rise again. The main short-term bullish trend remains dominant, with trading along an ascending line that supports this direction, benefiting from dynamic support provided by trading above the previous 50-day SMA. In addition, positive signals are appearing from the relative strength indicators after reaching extremely oversold levels.

Therefore, we expect the stock to rise in its upcoming trading sessions as long as the support level of $411.45 holds, targeting the key resistance level of $470.75 in preparation to test it.

Today’s stock forecast: Bullish.

Bristol-Myers Squibb Company (BMY) stock declined in its latest intraday trading after successfully correcting its oversold levels on the relative strength indicators. However, continued negative pressure from trading below the previous 50-day SMA reinforces the stability and strength of the main short-term bearish trend, especially with trading along a descending line that supports this direction.

Therefore, we expect the stock to decline in its upcoming trading sessions as long as the resistance level of $46.17 holds, targeting the key support level of $42.95.

Today’s stock forecast: Bearish.